Tengen, Germany

Ulf Koetz

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ulf Koetz: Innovator in Pharmaceutical Chemistry

Introduction

Ulf Koetz, an esteemed inventor based in Tengen, Germany, has made significant contributions to pharmaceutical chemistry with his innovative approaches. His work primarily focuses on the development of processes related to benzazepines, a class of compounds valuable for their therapeutic applications.

Latest Patents

Koetz holds a total of three patents, with his latest innovations revolving around the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. This compound is notably recognized for its potential as a serotonin (5-HT) receptor agonist, which can be beneficial in treating central nervous system disorders, including obesity. His inventions detail not only the processes and methods for synthesizing this compound but also cover its various salts, hydrates, and crystal forms.

Career Highlights

Ulf Koetz's professional journey includes a key role at Arena Pharmaceuticals, Inc., where he is engaged in pioneering research and development. His contributions to the field of medicinal chemistry have positioned him as a respected figure among his peers. His innovative spirit is reflected in his patent portfolio, which showcases his commitment to advancing therapeutic modalities.

Collaborations

Throughout his career, Koetz has collaborated with notable individuals in the field, including Ulrich Weigl and Frank Porstmann. These partnerships have fostered an environment of innovation and knowledge sharing, allowing Koetz to enhance his research and contribute effectively to the pharmaceutical landscape.

Conclusion

Ulf Koetz exemplifies the role of an innovative inventor who leverages his expertise to tackle significant health challenges. His patents not only underscore his dedication to pharmaceutical advancements but also highlight the importance of collaboration within the field. As he continues to explore new avenues of research, his work remains a testament to the potential impact of scientific innovation on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…